Connect with us

Business

AXIM® Biotechnologies Inc. (OTCMKTS:AXIM) Unveils its NeuCovix™ Test That Can Accurately Classify COVID-19 Neutralization Tests

Published

on

AXIM® Biotechnologies Inc. (OTCMKTS:AXIM) has completed a study focusing on the performance of its NeuCovix™ rapid test measuring the neutralizing levels of anti-COVID-19 antibodies.

NeuCovix™ accurately categorizes blood serum

The company compared the NeuCovix™ with the pseudovirus-based gold standard test. Results indicated that the NeuCovix™ test precisely categorized serum form COVID-19 patients that had strongly neutralized the SARS-CoV-2 as well as serum from those that had neutralized the virus poorly. Interestingly there was no cross-reaction with serum for the NeuCovix™ test for patients with seasonal respiratory infections that include seasonal coronavirus, which is an indication that the test has almost 100% specificity for SARS-CoV-2.

The current tests that use live viruses are expensive, time-consuming, and need highly trained personnel working in a tightly managed lab environment in measuring neutralizing antibodies. On the other hand, the NeuCovix™ test is cheap, portable, and quick point-of-care tests that determine the neutralizing antibody level in less than ten minutes. Considering the NeuCovix™ tests are in line with virus assay, it could prove to be an effective and affordable tool in monitoring huge numbers of subjects receiving vaccines for antibody neutralizing.

NeuCovix™ test is faster and less expensive

Also, NeuCovix™ can be used in measuring neutralizing antibodies levels in patients under that are receiving convalescent plasma or hyperimmune globulin to enable healthcare providers to determine the ideal neutralizing antibodies dosing that is in line with favorable results. John Huemoeller II, the CEO of AXIM® Biotech, stated that they were delighted with the preliminary test results showed by NeuCovix™. He added that the difference the tests deliver in time of money and time for vaccine developers and blood centers is huge.

AXIM® Biotech’s wholly-owned subsidiary, Sapphire Biotech’s Chief Scientific Officer Sergei Svarovusky, said that there is still work that needs to be done EUA. Sergei said that the 10-minute test has shown almost similar protective immune outcomes in samples of plasma from patients with high and low titers compared to the other time consuming and expensive lab tests.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Uncategorized1 day ago

Post Views: 147 Can you spot the difference between the hemp plant and marijuana plant? Hint: It’s not in the...

Business2 weeks ago

Stem Holdings Inc (OTCMKTS:STMH) Reports A Growth Of 960% In Q3 2020: Unveils TJGardens Branded Tinctures

Post Views: 377 Stem Holdings Inc (OTCMKTS:STMH) posted an increase of 960% YoY to $6.7 million in Q3 2020. It...

Business3 weeks ago

Indiva Ltd (OTCMKTS:NDVAF) Signs Three Provincial Agreements: Expands Distribution Network To Eight Provinces: Reports A Robust Growth Of 1273.7% In Q2 2020 Revenues

Post Views: 401 Indiva Ltd (OTCMKTS:NDVAF) posted a robust growth of 1273.7% YoY to CAD 2.826 million in revenues in...

Business3 weeks ago

4Front Ventures Corp (OTCMKTS:FFNTF) Receives Approval From CCC For Mission Dispensary and Cultivation Facilities In Worcester: Will Commence Adult-Use Cannabis Sales

Post Views: 376 CCC (Cannabis Control Commission) in Massachusetts approved cultivation and processing facilities and Mission Dispensary of 4Front Ventures...

Business3 weeks ago

Pure Sunfarms, A Joint Venture Of Village Farms International Inc (NASDAQ:VFF), Ships Bottled Oil Products TO British Columbia

Post Views: 500 Pure Sunfarms, which is a Village Farms International Inc (NASDAQ:VFF) JV, commenced shipment of Cannabis 2.0 products...

INDUSTRIAL HEMP3 weeks ago

Health Canada Grants Cannabis 2.0 License To Abba Medix Corp, An Auxiliary Of Canada House Cannabis Group Inc (OTCMKTS:SARSF)

Post Views: 396 Abba Medix Corp., a wholly-owned subsidiary of Canada House Cannabis Group Inc (OTCMKTS:SARSF), received an amended cannabis...